Cristina Rondinone
Founder & Chief Executive Officer Pep2Tango Therapeutics
Seminars
Thursday 3rd December 2026
Defining & Measuring the Quality of Amylin-Induced Weight Loss
10:00 am
- Compare methods for measuring fat mass, lean mass, visceral and subcutaneous adipose tissue, bone and broader metabolic changes
- Determine which measurements can be aligned from preclinical models through clinical trials to support meaningful comparison
- Establish what evidence would be needed to demonstrate that any body-composition benefit is specific to a molecule, mechanism or receptor profile
